Kiniksa Pharmaceuticals Ltd (KNSA) Insider Trading
- $71,248,379.44
- $17,510,695.66
- Dec. 5, 2024
- John F Paolini
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Dec. 5, 2024 | CFO | 1,123 | $21.25 | Sell | $23,863.75 | |
| Dec. 3, 2024 | CFO | 8,969 | $21.45 | Sell | $192,385.05 | |
| Oct. 15, 2024 | COO | 17,000 | $26.87 | Sell | $456,790.00 | |
| Sept. 23, 2024 | COO | 17,500 | $24.99 | Sell | $437,325.00 | |
| Sept. 3, 2024 | Insider | 60,692 | $26.12 | Sell | $1,585,275.04 | |
| Aug. 27, 2024 | COO | 17,500 | $26.91 | Sell | $470,925.00 | |
| July 23, 2024 | CFO | 24,248 | $24.79 | Sell | $601,107.92 | |
| July 23, 2024 | Insider | 22,000 | $26.32 | Sell | $579,040.00 | |
| July 23, 2024 | CEO | 136,124 | $25.65 | Sell | $3,491,580.60 | |
| March 6, 2024 | CEO | 5,582 | $21.00 | Sell | $117,222.00 | |
| March 4, 2024 | CEO | 12,742 | $21.49 | Sell | $273,825.58 | |
| March 1, 2024 | CAO | 9,659 | $21.45 | Sell | $207,185.55 | |
| Feb. 28, 2024 | CAO | 5,126 | $21.79 | Sell | $111,695.54 | |
| Jan. 3, 2024 | CFO | 12,000 | $20.00 | Sell | $240,000.00 | |
| Jan. 2, 2024 | CAO | 16,670 | $19.17 | Sell | $319,563.90 | |
| Dec. 19, 2023 | CAO | 9,316 | $19.13 | Sell | $178,215.08 | |
| Dec. 7, 2023 | Insider | 28,600 | $17.65 | Sell | $504,790.00 | |
| Sept. 5, 2023 | Insider | 400 | $17.53 | Sell | $7,012.00 | |
| July 25, 2023 | Insider | 29,000 | $19.14 | Sell | $555,060.00 | |
| Nov. 29, 2022 | Director | 21,959 | $16.15 | Sell | $354,637.85 | |
| Feb. 9, 2021 | CEO | 20,401 | $23.04 | Sell | $470,039.04 | |
| Feb. 3, 2021 | EVP | 2,477 | $22.09 | Sell | $54,716.93 | |
| Oct. 12, 2020 | CEO | 150,700 | $21.02 | Sell | $3,167,714.00 | |
| Oct. 9, 2020 | CEO | 872 | $21.00 | Sell | $18,312.00 | |
| July 1, 2020 | EVP | 29,589 | $25.37 | Sell | $750,672.93 | |
| June 10, 2020 | EVP | 13,752 | $25.07 | Sell | $344,762.64 | |
| April 20, 2020 | EVP | 47,423 | $19.06 | Sell | $903,882.38 | |
| March 6, 2020 | CEO | 33,115 | $20.00 | Sell | $662,300.00 | |
| Feb. 19, 2020 | SVP | 22,477 | $18.27 | Sell | $410,654.79 | |
| Feb. 14, 2020 | SVP | 1,039 | $18.33 | Sell | $19,044.87 | |
| Feb. 14, 2020 | EVP | 59 | $18.58 | Sell | $1,096.22 | |
| May 29, 2018 | Insider | 843,352 | $18.97 | Buy | $15,998,387.44 | |
| May 29, 2018 | Director | 3,000,000 | $18.00 | Buy | $54,000,000.00 | |
| May 29, 2018 | Major Shareholder | 69,444 | $18.00 | Buy | $1,249,992.00 |
Insiders are both buying and selling Kiniksa Pharmaceuticals Ltd stock.
The insider traders at Kiniksa Pharmaceuticals Ltd are: John F Paolini, Sanj K Patel, Thomas W Beetham, Mark Ragosa, Michael R Megna, Eben Tessari, Cormorant Asset Management, Lp, Barry D. Quart, Bros. Advisors Lp Baker, and James E Flynn
The most active insider trader at Kiniksa Pharmaceuticals Ltd is John F Paolini with 7 trades.
Sanj K Patel has sold the most Kiniksa Pharmaceuticals Ltd stock with a total value of $11,692,573.82.
Bros. Advisors Lp Baker has bought the most Kiniksa Pharmaceuticals Ltd stock with a total value of $108,000,000.00.
The most recent insider trade for Kiniksa Pharmaceuticals Ltd was on Dec. 5, 2024.
The single biggest insider buy for Kiniksa Pharmaceuticals Ltd was from Bros. Advisors Lp Baker with a total value of $54,000,000.00 on May 29, 2018.
The single biggest insider sell for Kiniksa Pharmaceuticals Ltd was from Sanj K Patel with a total value of $3,491,580.60 on July 23, 2024.